Research theme for competitive and other funds (7):
2019 - 2024 Exploration of molecular mechanism and therapeutic application of humoral tumor immunity based on sulfated-glycosaminoglycan antigens and immunogenomics
2020 - 2022 Development of Therapeutic Modality for Cancers by Reviving Ancient Signal Pathways That Human Has Lost During Evolution
2014 - 2017 Immunogenetic Repertoire Analysis for Tumor-infiltrating Lymphocytes - toward the Understanding of Tumor Immunology -
2014 - 2017 Multi-dimensional interactome analyses of patient derived cancer xenograft model for personalized medicine system
2014 - 2016 A novel screening method to identify any defined RNAi combinations to induce cell reprogramming.
Yoshiyuki Akiyama, Kaori Harada, Jimpei Miyakawa, Karl J Kreder, Michael A O'Donnell, Maeda Daichi, Hiroto Katoh, Miyuki Hori, Kensuke Owari, Kazunobu Futami, et al. Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis. iScience. 2023. 26. 11. 108262-108262
2018/03 - 東京医科歯科大学難治疾患研究所 優秀論文賞 Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B cell Antigens in Human Malignancies
2010/07 - 米国国防総省 Postdoctoral Fellowship Award, Breast Cancer Research Program (BRCP) Molecular Function of FOXP3 and its Reactivation for Breast Cancer Therapy
Association Membership(s) (6):
THE JAPANESE SOCIETY FOR HYGIENE
, THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
, THE JAPANESE SOCIETY OF PATHOLOGY
, American association for cancer research
, THE JAPANESE CANCER ASSOCIATION
, 日本産業衛生学会